Drivers of biodiagnostic development

Nature. 2009 Nov 26;462(7272):461-4. doi: 10.1038/nature08605.


The promise of point-of-care medical diagnostics - tests that can be carried out at the site of patient care - is enormous, bringing the benefits of fast and reliable testing and allowing rapid decisions on the course of treatment to be made. To this end, much innovation is occurring in technologies for use in biodiagnostic tests. Assays based on nanomaterials, for example, are now beginning to make the transition from the laboratory to the clinic. But the potential for such assays to become part of routine medical testing depends on many scientific factors, including sensitivity, selectivity and versatility, as well as technological, financial and policy factors.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Diagnostic Tests, Routine / instrumentation*
  • Diagnostic Tests, Routine / methods*
  • Diagnostic Tests, Routine / trends
  • Humans
  • Nanomedicine / instrumentation
  • Nanomedicine / methods
  • Point-of-Care Systems / trends
  • Sensitivity and Specificity